Diagnosticos da America S.A. (DASA3) Stock Statistics & Valuation Metrics

Diagnosticos da America S.A. has a market cap or net worth of R$3.29B. The enterprise value is $9.83K.

Diagnosticos da America S.A. has 1,255,007,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Diagnosticos da America S.A.’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is 6.19%.

The current PE Ratio of Diagnosticos da America S.A. is ―. Diagnosticos da America S.A.’s PEG ratio is 1.18.

In the last 12 months, Diagnosticos da America S.A. had revenue of 11.17B and earned -1.15B in profits. Earnings per share was -0.92.

In the last 12 months, operating cash flow was 435.63M and capital expenditures -216.37M, giving a free cash flow of 219.25M billion.

Diagnosticos da America S.A. pays an annual dividend of $0.097, resulting in a dividend yield of ―

Diagnosticos da America S.A. upcoming earnings date is Nov 5, 2026, TBA (Confirmed).

Diagnosticos da America S.A. as a current ratio of 1.24, with Debt / Equity ratio of 107.83%

In the past 12 months, Diagnosticos da America S.A. has paid 521.96M in taxes.

Diagnosticos da America S.A. EV to EBITDA ratio is 5.82, with an EV/FCF ratio of -36.35.

Diagnosticos da America S.A. has R$958.70M in cash and marketable securities with R$7.38B in debt, giving a net cash position of -R$6.42B billion.

Gross margin is 30.02%, with operating margin of 9.06%, and net profit margin of -10.31%.

The average price target for Diagnosticos da America S.A. is ―, which is 11.43% higher than the current price. The consensus rating is ―